Consumers say that smaller doses of a popular weight-loss drug eased side effects and improved their health Telehealth ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

The discussion surrounding GLP-1 medications needs to change to one that emphasizes science-based research and compassion.

Learn how GLP-1 medications support weight loss and heart health in perimenopause and postmenopause, plus get tips for ...

GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity or overweight with a related health condition. Read on for everything you need to know about GLP-1s for weight loss, ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) like semaglutide and liraglutide mimic endogenous incretin signals to stimulate glucose-dependent insulin release, thereby suppressing glucagon, ...

In a new trial, people who switched to the experimental daily GLP-1 pill orforglipron were able to keep off most of the weight they had lost taking Wegovy or Zepbound. People who switched from Wegovy ...

Brooke Boyarsky Pratt, CEO, and Dr. Angela Fitch, chief medical officer, are both co-founders of knownwell. More than 12% of U.S. adults now take a GLP-1 medication, marking one of the ...

Meals marketed for GLP-1 users are attracting non-users ...

Discover the top five ingredient trends driving GLP-1 innovation in the food and beverage industry. From proteins and fibers ...

While blockbuster drug innovations have changed health outcomes for decades, we’re now seeing signs that GLP-1 medications like Ozempic and Wegovy may be changing something broader: the consumer ...

Learn about the mixed bag of alternatives for people who can’t afford GLP-1 weight loss drugs like Ozempic.